GB2083820B - Aminothiazole oxime derivatives - Google Patents

Aminothiazole oxime derivatives

Info

Publication number
GB2083820B
GB2083820B GB8131634A GB8131634A GB2083820B GB 2083820 B GB2083820 B GB 2083820B GB 8131634 A GB8131634 A GB 8131634A GB 8131634 A GB8131634 A GB 8131634A GB 2083820 B GB2083820 B GB 2083820B
Authority
GB
United Kingdom
Prior art keywords
oxime derivatives
aminothiazole
aminothiazole oxime
derivatives
oxime
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB8131634A
Other languages
English (en)
Other versions
GB2083820A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Publication of GB2083820A publication Critical patent/GB2083820A/en
Application granted granted Critical
Publication of GB2083820B publication Critical patent/GB2083820B/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/587—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with aliphatic hydrocarbon radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms, said aliphatic radicals being substituted in the alpha-position to the ring by a hetero atom, e.g. with m >= 0, Z being a singly or a doubly bound hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB8131634A 1978-08-31 1979-08-28 Aminothiazole oxime derivatives Expired GB2083820B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7835195 1978-08-31

Publications (2)

Publication Number Publication Date
GB2083820A GB2083820A (en) 1982-03-31
GB2083820B true GB2083820B (en) 1983-02-16

Family

ID=10499378

Family Applications (1)

Application Number Title Priority Date Filing Date
GB8131634A Expired GB2083820B (en) 1978-08-31 1979-08-28 Aminothiazole oxime derivatives

Country Status (9)

Country Link
JP (1) JPS5533500A (enrdf_load_stackoverflow)
BE (1) BE878433A (enrdf_load_stackoverflow)
CH (1) CH642663A5 (enrdf_load_stackoverflow)
DE (1) DE2934682A1 (enrdf_load_stackoverflow)
ES (3) ES483676A1 (enrdf_load_stackoverflow)
FR (1) FR2434812A1 (enrdf_load_stackoverflow)
GB (1) GB2083820B (enrdf_load_stackoverflow)
NL (1) NL7906497A (enrdf_load_stackoverflow)
SE (1) SE7907159L (enrdf_load_stackoverflow)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2945248A1 (de) * 1978-11-13 1980-05-22 Fujisawa Pharmaceutical Co Cephem-verbindungen, verfahren zu ihrer herstellung und sie enthaltende antibakterielle pharmazeutische mittel
JPS5585594A (en) * 1978-11-13 1980-06-27 Fujisawa Pharmaceut Co Ltd Cephem compound and their preparation
JPS6011917B2 (ja) * 1981-04-09 1985-03-28 山之内製薬株式会社 新規なセファロスポリン化合物
JPS58986A (ja) * 1981-05-07 1983-01-06 Fujisawa Pharmaceut Co Ltd セフェム化合物
JPS5849382A (ja) * 1981-09-18 1983-03-23 Kyowa Hakko Kogyo Co Ltd β−ラクタム化合物
JPS58135894A (ja) * 1982-01-22 1983-08-12 Fujisawa Pharmaceut Co Ltd ７―置換ブチルアミド―３―ビニルセファロスポラン酸誘導体
JPS5973610A (ja) * 1982-10-20 1984-04-25 Tokico Ltd 油圧緩衝器
GB8432295D0 (en) * 1984-12-20 1985-01-30 Fujisawa Pharmaceutical Co Cephem compounds

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK159154C (da) * 1975-02-24 1991-02-11 Takeda Chemical Industries Ltd Fremgangsmaade til fremstilling af cephalosporinderivater eller salte deraf
GB1576625A (en) * 1976-04-12 1980-10-08 Fujisawa Pharmaceutical Co Syn isomer 3,7 disubstituted 3 cephem 4 carboxylic acid compounds and processes for the preparation thereof
DE2760484C2 (enrdf_load_stackoverflow) * 1976-04-14 1992-12-03 Takeda Chemical Industries, Ltd., Osaka, Jp
FR2381053A1 (fr) * 1977-02-18 1978-09-15 Roussel Uclaf Nouvelles oximes derivees de l'acide 3-thiadiazolyl thiomethyl 7-aminothiazolyl acetamido cephalosporanique, leur procede de preparation et leur application comme medicaments
PH17188A (en) * 1977-03-14 1984-06-14 Fujisawa Pharmaceutical Co New cephem and cepham compounds and their pharmaceutical compositions and method of use
DE2716677C2 (de) * 1977-04-15 1985-10-10 Hoechst Ag, 6230 Frankfurt Cephemderivate und Verfahren zu ihrer Herstellung
DE2714880A1 (de) * 1977-04-02 1978-10-26 Hoechst Ag Cephemderivate und verfahren zu ihrer herstellung
FR2387235A1 (fr) * 1978-01-23 1978-11-10 Fujisawa Pharmaceutical Co Procede de preparation de composes d'acide 3,7-disubstitue-3-cephem-4-carboxylique et nouveaux produits ainsi obtenus, ayant une forte activite antibacterienne
DE2804040C3 (de) * 1978-01-31 1981-03-19 Hoechst Ag, 6000 Frankfurt Verfahren zur Herstellung von Cephemverbindungen
SE7901262L (sv) * 1978-02-15 1979-08-16 Fujisawa Pharmaceutical Co 3,7-disubstituerade 3-cefem-4-karboxylsyraforeningar och forfarande for deras framstellning
US4341775A (en) * 1978-09-11 1982-07-27 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds

Also Published As

Publication number Publication date
ES483676A1 (es) 1980-09-01
FR2434812A1 (fr) 1980-03-28
NL7906497A (nl) 1980-03-04
ES8102109A1 (es) 1980-12-16
BE878433A (fr) 1980-02-25
CH642663A5 (de) 1984-04-30
DE2934682A1 (de) 1980-03-13
GB2083820A (en) 1982-03-31
FR2434812B1 (enrdf_load_stackoverflow) 1983-05-13
JPS6361954B2 (enrdf_load_stackoverflow) 1988-11-30
ES8102143A1 (es) 1980-12-16
ES490890A0 (es) 1980-12-16
SE7907159L (sv) 1980-03-01
JPS5533500A (en) 1980-03-08
ES490891A0 (es) 1980-12-16

Similar Documents

Publication Publication Date Title
GB2033893B (en) Tetrazolylalkoxycarbostyril derivatives
GB2022085B (en) Aminothiazoles
GB2012759B (en) Thienohydantoin derivatives
AU531302B2 (en) Oxime derivatives
GB2038822B (en) Thiazole derivatives
GB2022079B (en) L-leucyl-4-hydroxyanilide derivatives
AU533146B2 (en) Oxime derivatives
GB2083820B (en) Aminothiazole oxime derivatives
GB2018757B (en) 3-phenyltetrahydropyridine derivatives
GB2038326B (en) Acylaniline derivatives
AU522700B2 (en) Benzoin oxime derivatives
GB2017708B (en) Steroid-spirooxazolidinone derivatives
GB2036744B (en) Eburnane derivatives
JPS54148783A (en) Thiazolidine derivative
GB2019843B (en) N-alkenylmoranoline derivatives
GB2017691B (en) 2-hydroxymethyl-pyrazine derivatives
JPS5566589A (en) Aminothiazole compound
GB2052477B (en) Carbamoyl-piperazine derivatives
GB2024806B (en) Onomycin derivatives
GB2013187B (en) Phenylpyrol derivatives
GB2023574B (en) N-cyano-azomethine derivatives
JPS54100369A (en) Thiazolidine derivative
GB2029828B (en) Vincadifformine derivatives
GB2044251B (en) Phenoxypropanolamine derivatives
GB2031879B (en) Amidinopenem derivatives

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 19950828